Rank | Gene Set | Z-score |
---|---|---|
1 | blood coagulation, intrinsic pathway (GO:0007597) | 6.79143656 |
2 | negative regulation of norepinephrine secretion (GO:0010700) | 6.07016428 |
3 | low-density lipoprotein particle remodeling (GO:0034374) | 5.94808555 |
4 | thrombin receptor signaling pathway (GO:0070493) | 5.76593388 |
5 | protein neddylation (GO:0045116) | 5.72514660 |
6 | regulation of lipoprotein metabolic process (GO:0050746) | 5.21746170 |
7 | neutrophil activation involved in immune response (GO:0002283) | 4.81749309 |
8 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.80780291 |
9 | adenosine receptor signaling pathway (GO:0001973) | 4.62853024 |
10 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.56130253 |
11 | regulation of platelet activation (GO:0010543) | 4.55932478 |
12 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.51335395 |
13 | regulation of platelet aggregation (GO:0090330) | 4.48918002 |
14 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.40708212 |
15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.36466944 |
16 | neutral lipid catabolic process (GO:0046461) | 4.36144357 |
17 | acylglycerol catabolic process (GO:0046464) | 4.36144357 |
18 | low-density lipoprotein particle clearance (GO:0034383) | 4.33707769 |
19 | positive regulation of hemostasis (GO:1900048) | 4.33258475 |
20 | positive regulation of blood coagulation (GO:0030194) | 4.33258475 |
21 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 4.28222457 |
22 | triglyceride catabolic process (GO:0019433) | 4.27232157 |
23 | platelet aggregation (GO:0070527) | 4.26850463 |
24 | negative regulation of catecholamine secretion (GO:0033604) | 4.26493403 |
25 | regulation of norepinephrine secretion (GO:0014061) | 4.25398828 |
26 | negative regulation of platelet activation (GO:0010544) | 4.24057311 |
27 | platelet degranulation (GO:0002576) | 4.19213482 |
28 | angiogenesis involved in wound healing (GO:0060055) | 4.11990436 |
29 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.07289128 |
30 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.05205873 |
31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.96446936 |
32 | reverse cholesterol transport (GO:0043691) | 3.93745736 |
33 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.92516398 |
34 | positive regulation of coagulation (GO:0050820) | 3.90363442 |
35 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.86639475 |
36 | L-phenylalanine catabolic process (GO:0006559) | 3.86639475 |
37 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.82934806 |
38 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.82672335 |
39 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.80809713 |
40 | negative regulation of appetite (GO:0032099) | 3.77797181 |
41 | negative regulation of response to food (GO:0032096) | 3.77797181 |
42 | phospholipid homeostasis (GO:0055091) | 3.74738674 |
43 | regulation of sequestering of triglyceride (GO:0010889) | 3.67789031 |
44 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.63592874 |
45 | L-phenylalanine metabolic process (GO:0006558) | 3.63592874 |
46 | fatty acid elongation (GO:0030497) | 3.61148478 |
47 | fatty acid transmembrane transport (GO:1902001) | 3.59533448 |
48 | positive regulation of mast cell activation (GO:0033005) | 3.57721300 |
49 | positive regulation of fatty acid oxidation (GO:0046321) | 3.57623781 |
50 | negative regulation of protein localization to cell surface (GO:2000009) | 3.56594003 |
51 | plasma lipoprotein particle clearance (GO:0034381) | 3.53155720 |
52 | platelet activation (GO:0030168) | 3.51462685 |
53 | positive regulation of lipid catabolic process (GO:0050996) | 3.49684254 |
54 | complement activation, alternative pathway (GO:0006957) | 3.49555158 |
55 | cellular response to prostaglandin stimulus (GO:0071379) | 3.48552652 |
56 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.48206962 |
57 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.39861525 |
58 | regulation of cholesterol esterification (GO:0010872) | 3.39572763 |
59 | negative regulation of amine transport (GO:0051953) | 3.34220137 |
60 | regulation of triglyceride catabolic process (GO:0010896) | 3.33681111 |
61 | sulfur amino acid catabolic process (GO:0000098) | 3.25959318 |
62 | triglyceride homeostasis (GO:0070328) | 3.24428495 |
63 | acylglycerol homeostasis (GO:0055090) | 3.24428495 |
64 | glycerolipid catabolic process (GO:0046503) | 3.24373671 |
65 | response to dietary excess (GO:0002021) | 3.23870215 |
66 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.23734423 |
67 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.19625567 |
68 | locomotory exploration behavior (GO:0035641) | 3.18071373 |
69 | aromatic amino acid family catabolic process (GO:0009074) | 3.17618273 |
70 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.17459391 |
71 | bile acid biosynthetic process (GO:0006699) | 3.17317197 |
72 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.17076302 |
73 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.14778145 |
74 | alanine transport (GO:0032328) | 3.14222083 |
75 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.12594386 |
76 | carnitine shuttle (GO:0006853) | 3.11621114 |
77 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.11529892 |
78 | vocalization behavior (GO:0071625) | 3.11169181 |
79 | fatty acid beta-oxidation (GO:0006635) | 3.11022531 |
80 | acetyl-CoA metabolic process (GO:0006084) | 3.09709049 |
81 | negative regulation of heart rate (GO:0010459) | 3.08451611 |
82 | urea metabolic process (GO:0019627) | 3.06525040 |
83 | urea cycle (GO:0000050) | 3.06525040 |
84 | biotin metabolic process (GO:0006768) | 3.02501301 |
85 | cellular ketone body metabolic process (GO:0046950) | 3.01080221 |
86 | proline transport (GO:0015824) | 3.00915884 |
87 | regulation of endothelial cell differentiation (GO:0045601) | 2.98610428 |
88 | negative regulation of lipase activity (GO:0060192) | 2.96820359 |
89 | plasma lipoprotein particle organization (GO:0071827) | 2.96103303 |
90 | synaptic vesicle maturation (GO:0016188) | 2.95645770 |
91 | nucleobase catabolic process (GO:0046113) | 2.94890103 |
92 | negative regulation of hemostasis (GO:1900047) | 2.94664998 |
93 | negative regulation of blood coagulation (GO:0030195) | 2.94664998 |
94 | fatty acid oxidation (GO:0019395) | 2.94372539 |
95 | polyamine biosynthetic process (GO:0006596) | 2.93729668 |
96 | regulation of blood coagulation (GO:0030193) | 2.93718159 |
97 | regulation of hemostasis (GO:1900046) | 2.93718159 |
98 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.93140513 |
99 | valine metabolic process (GO:0006573) | 2.92418877 |
100 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.92237270 |
101 | positive regulation of receptor recycling (GO:0001921) | 2.91320271 |
102 | glutamate secretion (GO:0014047) | 2.91124969 |
103 | negative regulation of fibrinolysis (GO:0051918) | 2.90660827 |
104 | fatty acid catabolic process (GO:0009062) | 2.89561078 |
105 | lipoxygenase pathway (GO:0019372) | 2.89397715 |
106 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.89143775 |
107 | lipid oxidation (GO:0034440) | 2.89138386 |
108 | fibrinolysis (GO:0042730) | 2.88888813 |
109 | regulation of protein activation cascade (GO:2000257) | 2.88809443 |
110 | triglyceride biosynthetic process (GO:0019432) | 2.88469329 |
111 | bile acid metabolic process (GO:0008206) | 2.87955972 |
112 | triglyceride metabolic process (GO:0006641) | 2.85825775 |
113 | activation of protein kinase A activity (GO:0034199) | 2.85775908 |
114 | lysine catabolic process (GO:0006554) | 2.85541863 |
115 | lysine metabolic process (GO:0006553) | 2.85541863 |
116 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.84888288 |
117 | regulation of fatty acid oxidation (GO:0046320) | 2.84747498 |
118 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.84699313 |
119 | homotypic cell-cell adhesion (GO:0034109) | 2.84578537 |
120 | positive regulation of muscle hypertrophy (GO:0014742) | 2.84172680 |
121 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.84172680 |
122 | endothelium development (GO:0003158) | 2.83908109 |
123 | diacylglycerol metabolic process (GO:0046339) | 2.83447563 |
124 | high-density lipoprotein particle remodeling (GO:0034375) | 2.81192625 |
125 | neutral lipid biosynthetic process (GO:0046460) | 2.80958394 |
126 | acylglycerol biosynthetic process (GO:0046463) | 2.80958394 |
127 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.79387686 |
128 | nitrogen cycle metabolic process (GO:0071941) | 2.79221898 |
129 | neutral lipid metabolic process (GO:0006638) | 2.79154043 |
130 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.78932673 |
131 | fatty acid homeostasis (GO:0055089) | 2.78895754 |
132 | regulation of fibrinolysis (GO:0051917) | 2.78306909 |
133 | protein-lipid complex subunit organization (GO:0071825) | 2.78278607 |
134 | brown fat cell differentiation (GO:0050873) | 2.77810613 |
135 | negative regulation of amino acid transport (GO:0051956) | 2.77573677 |
136 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.77212465 |
137 | acylglycerol metabolic process (GO:0006639) | 2.77057559 |
138 | kynurenine metabolic process (GO:0070189) | 2.76065188 |
139 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.75918164 |
140 | regulation of complement activation (GO:0030449) | 2.75894014 |
141 | positive regulation of wound healing (GO:0090303) | 2.75657346 |
142 | cysteine metabolic process (GO:0006534) | 2.75492163 |
143 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.75135186 |
144 | regulation of cholesterol efflux (GO:0010874) | 2.74152992 |
145 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.71879076 |
146 | short-chain fatty acid metabolic process (GO:0046459) | 2.71257245 |
147 | monocarboxylic acid catabolic process (GO:0072329) | 2.71202755 |
148 | synaptic vesicle exocytosis (GO:0016079) | 2.70814948 |
149 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.70738524 |
150 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.70734027 |
151 | megakaryocyte development (GO:0035855) | 2.70545597 |
152 | 2-oxoglutarate metabolic process (GO:0006103) | 2.70492738 |
153 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.69923288 |
154 | thioester biosynthetic process (GO:0035384) | 2.69304596 |
155 | acyl-CoA biosynthetic process (GO:0071616) | 2.69304596 |
156 | glutamate metabolic process (GO:0006536) | 2.68931621 |
157 | response to prostaglandin E (GO:0034695) | 2.67795040 |
158 | mesodermal cell differentiation (GO:0048333) | 2.67633389 |
159 | regulation of coagulation (GO:0050818) | 2.67415866 |
160 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.66457801 |
161 | regulation of cholesterol storage (GO:0010885) | 2.65656452 |
162 | negative regulation of coagulation (GO:0050819) | 2.65367344 |
163 | epoxygenase P450 pathway (GO:0019373) | 2.65101437 |
164 | exploration behavior (GO:0035640) | 2.64037950 |
165 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.63845481 |
166 | regulation of lipid catabolic process (GO:0050994) | 2.63711724 |
167 | protein carboxylation (GO:0018214) | 2.63532647 |
168 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.63532647 |
169 | white fat cell differentiation (GO:0050872) | 2.63136586 |
170 | beta-amyloid metabolic process (GO:0050435) | 2.63111173 |
171 | plasma lipoprotein particle remodeling (GO:0034369) | 2.61737359 |
172 | protein-lipid complex remodeling (GO:0034368) | 2.61737359 |
173 | macromolecular complex remodeling (GO:0034367) | 2.61737359 |
174 | neutrophil activation (GO:0042119) | 2.60735910 |
175 | amino-acid betaine metabolic process (GO:0006577) | 2.60385262 |
176 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.60121868 |
177 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.59748701 |
178 | negative regulation of heart contraction (GO:0045822) | 2.55095721 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.82560281 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.56031621 |
3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.73476277 |
4 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.55697308 |
5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.55095023 |
6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.43563650 |
7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.87552310 |
8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.72613079 |
9 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48070993 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.46383449 |
11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.41855694 |
12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.39924656 |
13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.37103509 |
14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.33762741 |
15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.33686799 |
16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.30927244 |
17 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.29333068 |
18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.25586518 |
19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24858038 |
20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.22147073 |
21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.17174755 |
22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.17174755 |
23 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.02935864 |
24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.02385295 |
25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.00750504 |
26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.99510001 |
27 | GATA1_19941826_ChIP-Seq_K562_Human | 1.94326344 |
28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.91225895 |
29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.91224389 |
30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.88485991 |
31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.86160316 |
32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.85985302 |
33 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.84167920 |
34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.83922140 |
35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.82017378 |
36 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.80473884 |
37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79859242 |
38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.75984142 |
39 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.74505443 |
40 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.74148711 |
41 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72573165 |
42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.72143591 |
43 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.67761733 |
44 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.66425259 |
45 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.64550900 |
46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.63930245 |
47 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54452176 |
48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.52413574 |
49 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.50064498 |
50 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.49227807 |
51 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48409822 |
52 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.47209904 |
53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.46629920 |
54 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.46387092 |
55 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.45610743 |
56 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.44827754 |
57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44101383 |
58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41575872 |
59 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.41141688 |
60 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.38284589 |
61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38022883 |
62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.33222813 |
63 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30890419 |
64 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29732954 |
65 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.29208292 |
66 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.27871129 |
67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26734640 |
68 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25906911 |
69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25785863 |
70 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25299812 |
71 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.24696137 |
72 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24039027 |
73 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24014190 |
74 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.23114086 |
75 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.22758083 |
76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20247656 |
77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19900891 |
78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19492713 |
79 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.19475289 |
80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18010109 |
81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17779667 |
82 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17357131 |
83 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.17248335 |
84 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15625010 |
85 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.15510658 |
86 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14365672 |
87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14188450 |
88 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.14165476 |
89 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.13353706 |
90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11588408 |
91 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11059821 |
92 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10220672 |
93 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09479616 |
94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09104212 |
95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08755514 |
96 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08524232 |
97 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08447854 |
98 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.08397742 |
99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07499750 |
100 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06699584 |
101 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.06158621 |
102 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05840820 |
103 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05554144 |
104 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05320671 |
105 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05062135 |
106 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04060591 |
107 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04058522 |
108 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04058522 |
109 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03806898 |
110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03529183 |
111 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02833584 |
112 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02381904 |
113 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02152590 |
114 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02044425 |
115 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01647180 |
116 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.01009008 |
117 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.00085413 |
118 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99785073 |
119 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.99445134 |
120 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98844346 |
121 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98825142 |
122 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98683464 |
123 | P300_19829295_ChIP-Seq_ESCs_Human | 0.97753239 |
124 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97646866 |
125 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.97411499 |
126 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96471677 |
127 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.96166510 |
128 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95660517 |
129 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95626371 |
130 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.94818612 |
131 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94518752 |
132 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94401133 |
133 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94332948 |
134 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93438831 |
135 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.93363272 |
136 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92883168 |
137 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92406864 |
138 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91511554 |
139 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91335667 |
140 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90970349 |
141 | AR_19668381_ChIP-Seq_PC3_Human | 0.90800899 |
142 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90495802 |
143 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90232730 |
144 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90191900 |
145 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.90024029 |
146 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.89609548 |
147 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.88878842 |
148 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88692007 |
149 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.88566074 |
150 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88428812 |
151 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.88387373 |
152 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88132961 |
153 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87978958 |
154 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87663254 |
155 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87299543 |
156 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86382942 |
157 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85770737 |
158 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84675313 |
159 | STAT3_23295773_ChIP-Seq_U87_Human | 0.83968854 |
160 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83612065 |
161 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83457824 |
162 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79901147 |
163 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.78684488 |
164 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.77709238 |
165 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.77555744 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005464_abnormal_platelet_physiology | 8.25452812 |
2 | MP0008004_abnormal_stomach_pH | 4.58443610 |
3 | MP0004859_abnormal_synaptic_plasticity | 4.39314541 |
4 | MP0002139_abnormal_hepatobiliary_system | 4.28082972 |
5 | MP0005360_urolithiasis | 3.91483162 |
6 | MP0003724_increased_susceptibility_to | 3.60804036 |
7 | MP0005670_abnormal_white_adipose | 3.47166159 |
8 | MP0005365_abnormal_bile_salt | 3.45261265 |
9 | MP0003122_maternal_imprinting | 3.43071412 |
10 | MP0010329_abnormal_lipoprotein_level | 3.24327239 |
11 | MP0005085_abnormal_gallbladder_physiolo | 3.11304217 |
12 | MP0004130_abnormal_muscle_cell | 3.04643785 |
13 | MP0003880_abnormal_central_pattern | 2.83050886 |
14 | MP0000465_gastrointestinal_hemorrhage | 2.80543818 |
15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.62303749 |
16 | MP0002837_dystrophic_cardiac_calcinosis | 2.56859252 |
17 | MP0005084_abnormal_gallbladder_morpholo | 2.52472565 |
18 | MP0003635_abnormal_synaptic_transmissio | 2.49879241 |
19 | MP0004510_myositis | 2.49453859 |
20 | MP0005666_abnormal_adipose_tissue | 2.45204935 |
21 | MP0002876_abnormal_thyroid_physiology | 2.28209577 |
22 | MP0001501_abnormal_sleep_pattern | 2.23664409 |
23 | MP0002063_abnormal_learning/memory/cond | 2.11008999 |
24 | MP0002822_catalepsy | 2.06751657 |
25 | MP0000013_abnormal_adipose_tissue | 2.05687278 |
26 | MP0009745_abnormal_behavioral_response | 2.00819132 |
27 | MP0003566_abnormal_cell_adhesion | 2.00741969 |
28 | MP0004185_abnormal_adipocyte_glucose | 2.00193755 |
29 | MP0000343_altered_response_to | 2.00088248 |
30 | MP0009780_abnormal_chondrocyte_physiolo | 1.99644216 |
31 | MP0002118_abnormal_lipid_homeostasis | 1.99641899 |
32 | MP0003329_amyloid_beta_deposits | 1.99521107 |
33 | MP0004270_analgesia | 1.99220504 |
34 | MP0003191_abnormal_cellular_cholesterol | 1.96412172 |
35 | MP0005535_abnormal_body_temperature | 1.91947301 |
36 | MP0005375_adipose_tissue_phenotype | 1.87170244 |
37 | MP0002909_abnormal_adrenal_gland | 1.86795502 |
38 | MP0003303_peritoneal_inflammation | 1.85886092 |
39 | MP0006054_spinal_hemorrhage | 1.83619517 |
40 | MP0003828_pulmonary_edema | 1.77288537 |
41 | MP0003252_abnormal_bile_duct | 1.76289442 |
42 | MP0002971_abnormal_brown_adipose | 1.73802941 |
43 | MP0005058_abnormal_lysosome_morphology | 1.69702448 |
44 | MP0002064_seizures | 1.67234350 |
45 | MP0001879_abnormal_lymphatic_vessel | 1.65199392 |
46 | MP0000604_amyloidosis | 1.55028616 |
47 | MP0005332_abnormal_amino_acid | 1.54976455 |
48 | MP0002572_abnormal_emotion/affect_behav | 1.54917404 |
49 | MP0003690_abnormal_glial_cell | 1.51551036 |
50 | MP0003011_delayed_dark_adaptation | 1.51467613 |
51 | MP0005409_darkened_coat_color | 1.50746446 |
52 | MP0008775_abnormal_heart_ventricle | 1.49380850 |
53 | MP0002638_abnormal_pupillary_reflex | 1.49303742 |
54 | MP0005334_abnormal_fat_pad | 1.47497174 |
55 | MP0004084_abnormal_cardiac_muscle | 1.41984269 |
56 | MP0001968_abnormal_touch/_nociception | 1.40262930 |
57 | MP0000003_abnormal_adipose_tissue | 1.39379828 |
58 | MP0003705_abnormal_hypodermis_morpholog | 1.36714766 |
59 | MP0005646_abnormal_pituitary_gland | 1.35955876 |
60 | MP0000609_abnormal_liver_physiology | 1.35519937 |
61 | MP0001486_abnormal_startle_reflex | 1.31486956 |
62 | MP0003123_paternal_imprinting | 1.30000761 |
63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29612554 |
64 | MP0003638_abnormal_response/metabolism_ | 1.27645631 |
65 | MP0001851_eye_inflammation | 1.26325108 |
66 | MP0000249_abnormal_blood_vessel | 1.24562015 |
67 | MP0001440_abnormal_grooming_behavior | 1.23506633 |
68 | MP0002272_abnormal_nervous_system | 1.21895510 |
69 | MP0008438_abnormal_cutaneous_collagen | 1.21325690 |
70 | MP0005448_abnormal_energy_balance | 1.21226623 |
71 | MP0009115_abnormal_fat_cell | 1.20891661 |
72 | MP0003075_altered_response_to | 1.16818462 |
73 | MP0009046_muscle_twitch | 1.15076593 |
74 | MP0005410_abnormal_fertilization | 1.14734800 |
75 | MP0002736_abnormal_nociception_after | 1.13868510 |
76 | MP0000858_altered_metastatic_potential | 1.13332484 |
77 | MP0003121_genomic_imprinting | 1.12124171 |
78 | MP0006276_abnormal_autonomic_nervous | 1.11108834 |
79 | MP0002078_abnormal_glucose_homeostasis | 1.09771826 |
80 | MP0003633_abnormal_nervous_system | 1.06702039 |
81 | MP0005386_behavior/neurological_phenoty | 1.06611604 |
82 | MP0004924_abnormal_behavior | 1.06611604 |
83 | MP0005319_abnormal_enzyme/_coenzyme | 1.04896013 |
84 | MP0008874_decreased_physiological_sensi | 1.03518276 |
85 | MP0004858_abnormal_nervous_system | 1.03492605 |
86 | MP0002734_abnormal_mechanical_nocicepti | 1.03242025 |
87 | MP0002733_abnormal_thermal_nociception | 1.01657499 |
88 | MP0010234_abnormal_vibrissa_follicle | 0.98428885 |
89 | MP0008872_abnormal_physiological_respon | 0.98238960 |
90 | MP0009840_abnormal_foam_cell | 0.97767350 |
91 | MP0001666_abnormal_nutrient_absorption | 0.97304450 |
92 | MP0002254_reproductive_system_inflammat | 0.97005273 |
93 | MP0001915_intracranial_hemorrhage | 0.96624922 |
94 | MP0002970_abnormal_white_adipose | 0.95540657 |
95 | MP0009763_increased_sensitivity_to | 0.95306165 |
96 | MP0005167_abnormal_blood-brain_barrier | 0.94762469 |
97 | MP0000751_myopathy | 0.94360364 |
98 | MP0003656_abnormal_erythrocyte_physiolo | 0.93443850 |
99 | MP0003959_abnormal_lean_body | 0.93158913 |
100 | MP0009642_abnormal_blood_homeostasis | 0.93041709 |
101 | MP0001544_abnormal_cardiovascular_syste | 0.91933208 |
102 | MP0005385_cardiovascular_system_phenoty | 0.91933208 |
103 | MP0008961_abnormal_basal_metabolism | 0.91279428 |
104 | MP0005187_abnormal_penis_morphology | 0.89855428 |
105 | MP0003195_calcinosis | 0.89725141 |
106 | MP0001177_atelectasis | 0.88957274 |
107 | MP0004019_abnormal_vitamin_homeostasis | 0.88926443 |
108 | MP0002069_abnormal_eating/drinking_beha | 0.88820960 |
109 | MP0010368_abnormal_lymphatic_system | 0.88583593 |
110 | MP0002090_abnormal_vision | 0.88008400 |
111 | MP0004272_abnormal_basement_membrane | 0.86859565 |
112 | MP0002132_abnormal_respiratory_system | 0.85587922 |
113 | MP0002128_abnormal_blood_circulation | 0.85057872 |
114 | MP0001764_abnormal_homeostasis | 0.84013593 |
115 | MP0005083_abnormal_biliary_tract | 0.84005424 |
116 | MP0001970_abnormal_pain_threshold | 0.79853044 |
117 | MP0005452_abnormal_adipose_tissue | 0.79535765 |
118 | MP0002067_abnormal_sensory_capabilities | 0.79208098 |
119 | MP0004811_abnormal_neuron_physiology | 0.79189558 |
120 | MP0003879_abnormal_hair_cell | 0.79172694 |
121 | MP0004484_altered_response_of | 0.78644316 |
122 | MP0004883_abnormal_blood_vessel | 0.77711261 |
123 | MP0004215_abnormal_myocardial_fiber | 0.76856905 |
124 | MP0005275_abnormal_skin_tensile | 0.76338727 |
125 | MP0003631_nervous_system_phenotype | 0.75276050 |
126 | MP0005595_abnormal_vascular_smooth | 0.75136835 |
127 | MP0000639_abnormal_adrenal_gland | 0.75132515 |
128 | MP0005423_abnormal_somatic_nervous | 0.74462533 |
129 | MP0002066_abnormal_motor_capabilities/c | 0.74175141 |
130 | MP0001661_extended_life_span | 0.74081685 |
131 | MP0005620_abnormal_muscle_contractility | 0.73079429 |
132 | MP0003632_abnormal_nervous_system | 0.72526068 |
133 | MP0002972_abnormal_cardiac_muscle | 0.71647508 |
134 | MP0003953_abnormal_hormone_level | 0.70590735 |
135 | MP0003300_gastrointestinal_ulcer | 0.70582444 |
136 | MP0006138_congestive_heart_failure | 0.69960684 |
137 | MP0003186_abnormal_redox_activity | 0.69374977 |
138 | MP0003806_abnormal_nucleotide_metabolis | 0.69274846 |
139 | MP0002735_abnormal_chemical_nociception | 0.68693488 |
140 | MP0004036_abnormal_muscle_relaxation | 0.68606347 |
141 | MP0004142_abnormal_muscle_tone | 0.67596982 |
142 | MP0001663_abnormal_digestive_system | 0.67008310 |
143 | MP0008569_lethality_at_weaning | 0.66988964 |
144 | MP0002089_abnormal_postnatal_growth/wei | 0.65996320 |
145 | MP0003172_abnormal_lysosome_physiology | 0.65843155 |
146 | MP0003868_abnormal_feces_composition | 0.65300742 |
147 | MP0005647_abnormal_sex_gland | 0.64900925 |
148 | MP0000230_abnormal_systemic_arterial | 0.64484232 |
149 | MP0000598_abnormal_liver_morphology | 0.64173445 |
150 | MP0002998_abnormal_bone_remodeling | 0.63662257 |
151 | MP0002557_abnormal_social/conspecific_i | 0.62167775 |
152 | MP0001545_abnormal_hematopoietic_system | 0.61819881 |
153 | MP0005397_hematopoietic_system_phenotyp | 0.61819881 |
154 | MP0002184_abnormal_innervation | 0.60908489 |
155 | MP0006036_abnormal_mitochondrial_physio | 0.60547677 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormal platelet volume (HP:0011876) | 9.37002650 |
2 | Purpura (HP:0000979) | 8.86346985 |
3 | Petechiae (HP:0000967) | 7.31110360 |
4 | Epistaxis (HP:0000421) | 6.63293380 |
5 | Gingival bleeding (HP:0000225) | 6.39588516 |
6 | Acanthocytosis (HP:0001927) | 4.96626160 |
7 | Abnormal platelet function (HP:0011869) | 4.68615086 |
8 | Impaired platelet aggregation (HP:0003540) | 4.68615086 |
9 | Deep venous thrombosis (HP:0002625) | 4.46096074 |
10 | Focal motor seizures (HP:0011153) | 4.23440385 |
11 | Complement deficiency (HP:0004431) | 4.18333595 |
12 | Poikilocytosis (HP:0004447) | 4.18148426 |
13 | Xanthomatosis (HP:0000991) | 4.17923860 |
14 | Hyperlipoproteinemia (HP:0010980) | 4.06221553 |
15 | Myokymia (HP:0002411) | 3.81461359 |
16 | Epidermoid cyst (HP:0200040) | 3.66323899 |
17 | Oligomenorrhea (HP:0000876) | 3.60053140 |
18 | Spontaneous hematomas (HP:0007420) | 3.58020322 |
19 | Hyperglycinuria (HP:0003108) | 3.55371952 |
20 | Ketosis (HP:0001946) | 3.45745206 |
21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.42305096 |
22 | Abnormality of glycine metabolism (HP:0010895) | 3.32475418 |
23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.32475418 |
24 | Cerebral inclusion bodies (HP:0100314) | 3.27611089 |
25 | Intrahepatic cholestasis (HP:0001406) | 3.24739320 |
26 | Papillary thyroid carcinoma (HP:0002895) | 3.20021826 |
27 | Focal seizures (HP:0007359) | 3.16775737 |
28 | Conjunctival telangiectasia (HP:0000524) | 3.15580815 |
29 | Hypoalphalipoproteinemia (HP:0003233) | 3.14580958 |
30 | Hyperammonemia (HP:0001987) | 3.12757784 |
31 | Hyperventilation (HP:0002883) | 3.12635871 |
32 | Hypobetalipoproteinemia (HP:0003563) | 3.11168586 |
33 | Hyperglycinemia (HP:0002154) | 3.09106176 |
34 | Dyschromatopsia (HP:0007641) | 3.05807008 |
35 | Prolonged partial thromboplastin time (HP:0003645) | 3.05527082 |
36 | Acanthosis nigricans (HP:0000956) | 2.97798157 |
37 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.94122731 |
38 | Hypertriglyceridemia (HP:0002155) | 2.93516351 |
39 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.93062368 |
40 | Hypolipoproteinemia (HP:0010981) | 2.92220664 |
41 | Ketoacidosis (HP:0001993) | 2.91548276 |
42 | Neurofibrillary tangles (HP:0002185) | 2.89969234 |
43 | Abnormality of complement system (HP:0005339) | 2.87328417 |
44 | Visual hallucinations (HP:0002367) | 2.85864439 |
45 | Abnormal pupillary function (HP:0007686) | 2.82025621 |
46 | Impaired social interactions (HP:0000735) | 2.80511362 |
47 | Abnormal social behavior (HP:0012433) | 2.80511362 |
48 | Bruising susceptibility (HP:0000978) | 2.80157629 |
49 | Skin nodule (HP:0200036) | 2.79070041 |
50 | Poor eye contact (HP:0000817) | 2.71728483 |
51 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.70079268 |
52 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.68164927 |
53 | Abnormality of the lower motor neuron (HP:0002366) | 2.63055642 |
54 | Hypercholesterolemia (HP:0003124) | 2.60723864 |
55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.55088931 |
56 | Hypoglycemic coma (HP:0001325) | 2.54910467 |
57 | Absence seizures (HP:0002121) | 2.52585128 |
58 | Generalized tonic-clonic seizures (HP:0002069) | 2.52035270 |
59 | Hypophosphatemic rickets (HP:0004912) | 2.50058638 |
60 | Abnormal eating behavior (HP:0100738) | 2.48965769 |
61 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.39936943 |
62 | Torticollis (HP:0000473) | 2.38568888 |
63 | Status epilepticus (HP:0002133) | 2.37020441 |
64 | Nausea (HP:0002018) | 2.36785495 |
65 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.35193013 |
66 | Action tremor (HP:0002345) | 2.33077120 |
67 | Abnormality of the common coagulation pathway (HP:0010990) | 2.32625713 |
68 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.31984735 |
69 | Upper limb muscle weakness (HP:0003484) | 2.31838086 |
70 | Epileptic encephalopathy (HP:0200134) | 2.31608968 |
71 | Supranuclear gaze palsy (HP:0000605) | 2.30763244 |
72 | Amyloidosis (HP:0011034) | 2.30685041 |
73 | Focal dystonia (HP:0004373) | 2.26782589 |
74 | Abnormality of the Achilles tendon (HP:0005109) | 2.24940934 |
75 | Myocardial infarction (HP:0001658) | 2.22634338 |
76 | Atonic seizures (HP:0010819) | 2.21880525 |
77 | Sensorimotor neuropathy (HP:0007141) | 2.21431836 |
78 | Paralysis (HP:0003470) | 2.21058316 |
79 | Anxiety (HP:0000739) | 2.20338334 |
80 | Global brain atrophy (HP:0002283) | 2.20183130 |
81 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.19516233 |
82 | Craniofacial dystonia (HP:0012179) | 2.19472378 |
83 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.17014031 |
84 | Dialeptic seizures (HP:0011146) | 2.16733470 |
85 | Leiomyosarcoma (HP:0100243) | 2.16389268 |
86 | Uterine leiomyosarcoma (HP:0002891) | 2.16389268 |
87 | Arthropathy (HP:0003040) | 2.14231816 |
88 | Delayed CNS myelination (HP:0002188) | 2.13041054 |
89 | Joint swelling (HP:0001386) | 2.11818305 |
90 | Dysdiadochokinesis (HP:0002075) | 2.11260332 |
91 | Testicular neoplasm (HP:0010788) | 2.09126016 |
92 | Spontaneous abortion (HP:0005268) | 2.08799999 |
93 | Thyroid carcinoma (HP:0002890) | 2.08179365 |
94 | Abnormal gallbladder physiology (HP:0012438) | 2.07278297 |
95 | Cholecystitis (HP:0001082) | 2.07278297 |
96 | Amblyopia (HP:0000646) | 2.07148283 |
97 | Increased density of long bones (HP:0006392) | 2.05973166 |
98 | Drooling (HP:0002307) | 2.03971926 |
99 | Excessive salivation (HP:0003781) | 2.03971926 |
100 | Glomerulonephritis (HP:0000099) | 2.03435088 |
101 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.03059378 |
102 | Myoglobinuria (HP:0002913) | 2.02974699 |
103 | Abnormality of proline metabolism (HP:0010907) | 2.01821272 |
104 | Hydroxyprolinuria (HP:0003080) | 2.01821272 |
105 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.01487125 |
106 | Menorrhagia (HP:0000132) | 10.5262394 |
107 | Prolonged bleeding time (HP:0003010) | 10.4144201 |
108 | Increased mean platelet volume (HP:0011877) | 10.0953024 |
109 | Neonatal onset (HP:0003623) | 1.99548794 |
110 | Intention tremor (HP:0002080) | 1.98446620 |
111 | Depression (HP:0000716) | 1.98249110 |
112 | Joint hemorrhage (HP:0005261) | 1.96752848 |
113 | Dysmetria (HP:0001310) | 1.96140883 |
114 | Bladder neoplasm (HP:0009725) | 1.95851118 |
115 | Bladder carcinoma (HP:0002862) | 1.95851118 |
116 | Pigmentary retinal degeneration (HP:0001146) | 1.94615495 |
117 | Hyperthyroidism (HP:0000836) | 1.94408783 |
118 | Hepatosplenomegaly (HP:0001433) | 1.93764617 |
119 | Back pain (HP:0003418) | 1.92499504 |
120 | Postural instability (HP:0002172) | 1.91896761 |
121 | Achilles tendon contracture (HP:0001771) | 1.91581597 |
122 | Abnormality of lateral ventricle (HP:0030047) | 1.88925990 |
123 | Hemorrhage of the eye (HP:0011885) | 1.88820945 |
124 | Generalized aminoaciduria (HP:0002909) | 1.88293786 |
125 | Insidious onset (HP:0003587) | 1.87634288 |
126 | Termporal pattern (HP:0011008) | 1.87634288 |
127 | Dysmetric saccades (HP:0000641) | 1.87627727 |
128 | Abnormality of serum amino acid levels (HP:0003112) | 1.84570662 |
129 | Polycythemia (HP:0001901) | 1.82744329 |
130 | Impaired vibratory sensation (HP:0002495) | 1.82710631 |
131 | Cerebral hemorrhage (HP:0001342) | 1.82566681 |
132 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.82020794 |
133 | Growth hormone excess (HP:0000845) | 1.81826539 |
134 | Abnormal auditory evoked potentials (HP:0006958) | 1.81384079 |
135 | Turricephaly (HP:0000262) | 1.80585459 |
136 | Febrile seizures (HP:0002373) | 1.80378760 |
137 | Systemic lupus erythematosus (HP:0002725) | 1.79682866 |
138 | Mitral stenosis (HP:0001718) | 1.79547459 |
139 | Epileptiform EEG discharges (HP:0011182) | 1.79257085 |
140 | Hemiplegia (HP:0002301) | 1.78616837 |
141 | Episodic fever (HP:0001954) | 1.77475933 |
142 | Thrombophlebitis (HP:0004418) | 1.76302472 |
143 | Polygenic inheritance (HP:0010982) | 1.75234645 |
144 | Polyphagia (HP:0002591) | 1.74837194 |
145 | Decreased central vision (HP:0007663) | 1.74370058 |
146 | Metabolic acidosis (HP:0001942) | 1.73788340 |
147 | Cholelithiasis (HP:0001081) | 1.73547178 |
148 | Resting tremor (HP:0002322) | 1.73188877 |
149 | Papilledema (HP:0001085) | 1.72325351 |
150 | Abnormality of macrophages (HP:0004311) | 1.65487898 |
151 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.62166254 |
152 | Broad palm (HP:0001169) | 1.62153546 |
153 | Broad alveolar ridges (HP:0000187) | 1.62017967 |
154 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.56483202 |
155 | Gonadal dysgenesis (HP:0000133) | 1.54672316 |
156 | Diplopia (HP:0000651) | 1.52550946 |
157 | Abnormality of binocular vision (HP:0011514) | 1.52550946 |
158 | Biliary tract neoplasm (HP:0100574) | 1.52477712 |
159 | Tetraparesis (HP:0002273) | 1.50933904 |
160 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.49860289 |
161 | Gastrointestinal carcinoma (HP:0002672) | 1.49860289 |
162 | Rickets (HP:0002748) | 1.48002030 |
163 | Delayed puberty (HP:0000823) | 1.47822197 |
164 | Dysostosis multiplex (HP:0000943) | 1.46534146 |
165 | Abnormality of iron homeostasis (HP:0011031) | 1.39888036 |
166 | Irregular epiphyses (HP:0010582) | 1.39480424 |
167 | Arterial thrombosis (HP:0004420) | 1.36757688 |
168 | Renal cell carcinoma (HP:0005584) | 1.34353444 |
169 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.34344802 |
170 | Abnormality of alanine metabolism (HP:0010916) | 1.34344802 |
171 | Hyperalaninemia (HP:0003348) | 1.34344802 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 4.92477135 |
2 | EIF2AK1 | 3.79523516 |
3 | NTRK3 | 3.51315294 |
4 | BMX | 3.41992886 |
5 | MST4 | 3.04133430 |
6 | MAP3K9 | 2.69999559 |
7 | DAPK2 | 2.68601050 |
8 | TRIB3 | 2.64519562 |
9 | MYLK | 2.45190939 |
10 | KSR2 | 2.41415594 |
11 | RIPK4 | 2.36224742 |
12 | MAP2K4 | 2.35433911 |
13 | CAMK1D | 2.32078542 |
14 | MAP3K4 | 2.24626303 |
15 | CAMK1G | 2.23756385 |
16 | MINK1 | 2.16298053 |
17 | BCKDK | 2.13755831 |
18 | TEC | 1.96613552 |
19 | SIK1 | 1.90231243 |
20 | STK3 | 1.87481569 |
21 | PRKD3 | 1.86416429 |
22 | MARK1 | 1.82766404 |
23 | PAK6 | 1.79611805 |
24 | CSF1R | 1.79128192 |
25 | TRIM28 | 1.71014031 |
26 | STK24 | 1.68816251 |
27 | TNIK | 1.68443732 |
28 | SYK | 1.64764080 |
29 | BTK | 1.63059659 |
30 | KSR1 | 1.61990497 |
31 | PTK2B | 1.60097256 |
32 | CAMKK1 | 1.54270687 |
33 | NTRK1 | 1.48579762 |
34 | MAP3K13 | 1.46810998 |
35 | MAP2K7 | 1.42815753 |
36 | DAPK1 | 1.38672925 |
37 | SIK2 | 1.35678981 |
38 | YES1 | 1.35130857 |
39 | RIPK1 | 1.29918082 |
40 | MAP3K2 | 1.29134422 |
41 | LATS2 | 1.29108275 |
42 | BCR | 1.27455938 |
43 | SIK3 | 1.24357097 |
44 | CDK5 | 1.23902372 |
45 | ILK | 1.19568727 |
46 | PDK3 | 1.18785163 |
47 | PDK4 | 1.18785163 |
48 | EPHA3 | 1.16668862 |
49 | MAP3K5 | 1.16288294 |
50 | PLK2 | 1.13905743 |
51 | RET | 1.11628975 |
52 | CASK | 1.11191669 |
53 | GRK5 | 1.11036429 |
54 | NTRK2 | 1.10439869 |
55 | MAP3K12 | 1.06892933 |
56 | STK38 | 1.06852409 |
57 | PKN2 | 1.05859334 |
58 | ARAF | 1.05743666 |
59 | SGK2 | 1.04707418 |
60 | FGFR2 | 1.03921276 |
61 | LMTK2 | 1.00997494 |
62 | MAP2K1 | 1.00989414 |
63 | MST1R | 0.98643261 |
64 | RAF1 | 0.97029724 |
65 | PDPK1 | 0.95581067 |
66 | ZAP70 | 0.95334543 |
67 | ACVR1B | 0.94473485 |
68 | DYRK2 | 0.93897881 |
69 | TYRO3 | 0.93432720 |
70 | INSRR | 0.92960707 |
71 | FRK | 0.91382780 |
72 | ERBB2 | 0.90395409 |
73 | PRKCG | 0.90212538 |
74 | FES | 0.88836000 |
75 | PDK1 | 0.88520285 |
76 | HCK | 0.88411280 |
77 | PINK1 | 0.84370581 |
78 | DYRK1B | 0.83724603 |
79 | MAP3K7 | 0.83401297 |
80 | CAMK1 | 0.82794567 |
81 | MAP3K6 | 0.80440038 |
82 | PRKCH | 0.80052645 |
83 | PAK3 | 0.79576281 |
84 | FER | 0.79023399 |
85 | BMPR2 | 0.78408910 |
86 | CAMK2A | 0.77710942 |
87 | PDGFRA | 0.76721597 |
88 | ADRBK2 | 0.76365704 |
89 | MATK | 0.75499818 |
90 | PIK3CG | 0.75029038 |
91 | PRKAA2 | 0.73498051 |
92 | PDGFRB | 0.73296555 |
93 | PRKCZ | 0.72703254 |
94 | PAK1 | 0.69970187 |
95 | ERN1 | 0.69598268 |
96 | STK11 | 0.68171954 |
97 | LYN | 0.67485457 |
98 | PHKG2 | 0.67166652 |
99 | PHKG1 | 0.67166652 |
100 | NEK9 | 0.66980746 |
101 | PRKG1 | 0.66471823 |
102 | BLK | 0.66288636 |
103 | MAPK13 | 0.65867219 |
104 | PKN1 | 0.63890917 |
105 | IRAK1 | 0.62221706 |
106 | CAMK2B | 0.61305892 |
107 | MAPK12 | 0.60264098 |
108 | CSK | 0.59063210 |
109 | CAMKK2 | 0.58402516 |
110 | PRKACG | 0.56485779 |
111 | FGFR4 | 0.56422968 |
112 | SGK1 | 0.55835755 |
113 | FGR | 0.55333982 |
114 | MAP3K1 | 0.55316381 |
115 | ABL2 | 0.55097801 |
116 | PNCK | 0.55064338 |
117 | TAOK1 | 0.51689543 |
118 | ADRBK1 | 0.51461918 |
119 | FGFR3 | 0.51166226 |
120 | MAP2K3 | 0.50644966 |
121 | PRPF4B | 0.50009045 |
122 | CDK14 | 0.48771219 |
123 | SGK3 | 0.48669890 |
124 | MAP4K2 | 0.48324732 |
125 | DYRK1A | 0.47352886 |
126 | JAK2 | 0.46687204 |
127 | DDR2 | 0.45705933 |
128 | GRK6 | 0.45329362 |
129 | SGK494 | 0.44843626 |
130 | SGK223 | 0.44843626 |
131 | EPHB2 | 0.44426044 |
132 | FGFR1 | 0.44208920 |
133 | RPS6KA3 | 0.43937026 |
134 | CDK15 | 0.43451065 |
135 | CDK18 | 0.42301702 |
136 | ERBB3 | 0.42237905 |
137 | FYN | 0.41859616 |
138 | PRKD1 | 0.41513631 |
139 | SRC | 0.41478849 |
140 | TGFBR2 | 0.41157526 |
141 | CSNK1G2 | 0.40860859 |
142 | MARK2 | 0.40693296 |
143 | PRKAA1 | 0.40492958 |
144 | PDK2 | 0.40034701 |
145 | TAOK3 | 0.39290668 |
146 | MOS | 0.38378065 |
147 | DAPK3 | 0.37010083 |
148 | CAMK2G | 0.36335200 |
149 | JAK1 | 0.34798969 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Platelet activation_Homo sapiens_hsa04611 | 4.35185017 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.50399900 |
3 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.88831565 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.83313521 |
5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.46771078 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.28229931 |
7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.24352146 |
8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.23390775 |
9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.21021728 |
10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.06898251 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.04568112 |
12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.96641984 |
13 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.92091210 |
14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.87146501 |
15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.85405029 |
16 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.82641254 |
17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77145473 |
18 | Nicotine addiction_Homo sapiens_hsa05033 | 1.73915502 |
19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.71422627 |
20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.71384242 |
21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68417671 |
22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.61865860 |
23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61377279 |
24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.60773012 |
25 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.60622544 |
26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.50019008 |
27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.49158419 |
28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.47656559 |
29 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.44702870 |
30 | Long-term potentiation_Homo sapiens_hsa04720 | 1.43603152 |
31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43419366 |
32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36523517 |
33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.34230325 |
34 | Bile secretion_Homo sapiens_hsa04976 | 1.32633095 |
35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.32181728 |
36 | Circadian entrainment_Homo sapiens_hsa04713 | 1.30268887 |
37 | Peroxisome_Homo sapiens_hsa04146 | 1.29344737 |
38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29189265 |
39 | Renin secretion_Homo sapiens_hsa04924 | 1.28166702 |
40 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.25766209 |
41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25751935 |
42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.23542660 |
43 | Salivary secretion_Homo sapiens_hsa04970 | 1.22451015 |
44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.20363743 |
45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19654371 |
46 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.19326218 |
47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.16999589 |
48 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.15105320 |
49 | Morphine addiction_Homo sapiens_hsa05032 | 1.13942789 |
50 | Olfactory transduction_Homo sapiens_hsa04740 | 1.12119684 |
51 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.08924240 |
52 | Alcoholism_Homo sapiens_hsa05034 | 1.08625917 |
53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.08287627 |
54 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.06573036 |
55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05690343 |
56 | Endocytosis_Homo sapiens_hsa04144 | 1.02423905 |
57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.02065211 |
58 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.00267688 |
59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00064258 |
60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.99343468 |
61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97905505 |
62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96879563 |
63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93244290 |
64 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.90637528 |
65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90420263 |
66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89951914 |
67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88984916 |
68 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.87282446 |
69 | Focal adhesion_Homo sapiens_hsa04510 | 0.86702894 |
70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86233709 |
71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85880964 |
72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.84288877 |
73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82761369 |
74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.82152923 |
75 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.81082990 |
76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80982065 |
77 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.80579214 |
78 | Adherens junction_Homo sapiens_hsa04520 | 0.80153623 |
79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79165965 |
80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78430296 |
81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77352940 |
82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75827195 |
83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74601811 |
84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.74383301 |
85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74137254 |
86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73614463 |
87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73608586 |
88 | Insulin secretion_Homo sapiens_hsa04911 | 0.73306238 |
89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72659261 |
90 | Phagosome_Homo sapiens_hsa04145 | 0.72374391 |
91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69911983 |
92 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69488144 |
93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68398768 |
94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68285927 |
95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67860335 |
96 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67709040 |
97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67689086 |
98 | Long-term depression_Homo sapiens_hsa04730 | 0.66640394 |
99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65672143 |
100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65031897 |
101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64244728 |
102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64217605 |
103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63739875 |
104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63130048 |
105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61767196 |
106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60963552 |
107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60119285 |
108 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59856841 |
109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59039870 |
110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58638243 |
111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58310954 |
112 | Insulin resistance_Homo sapiens_hsa04931 | 0.58127996 |
113 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57929329 |
114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57266820 |
115 | Glioma_Homo sapiens_hsa05214 | 0.57024599 |
116 | ABC transporters_Homo sapiens_hsa02010 | 0.56591204 |
117 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56134417 |
118 | Prion diseases_Homo sapiens_hsa05020 | 0.55320068 |
119 | Taste transduction_Homo sapiens_hsa04742 | 0.53961733 |
120 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53595246 |
121 | Shigellosis_Homo sapiens_hsa05131 | 0.53210109 |
122 | Gap junction_Homo sapiens_hsa04540 | 0.51817513 |
123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50698771 |
124 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49748275 |
125 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48154937 |
126 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47316119 |
127 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47077358 |
128 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.46060854 |
129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44226032 |
130 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44165148 |
131 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42223602 |
132 | Melanogenesis_Homo sapiens_hsa04916 | 0.41622705 |
133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41426189 |
134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40754447 |
135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40712859 |
136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40701038 |
137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40353354 |
138 | Malaria_Homo sapiens_hsa05144 | 0.39964494 |
139 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39566811 |
140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39149833 |
141 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38741929 |
142 | Axon guidance_Homo sapiens_hsa04360 | 0.38610585 |
143 | Amoebiasis_Homo sapiens_hsa05146 | 0.38193214 |
144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36512956 |
145 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36318154 |
146 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34595248 |
147 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33651772 |